Your browser doesn't support javascript.
loading
Human Fc Receptor-like 3 Inhibits Regulatory T Cell Function and Binds Secretory IgA.
Agarwal, Stuti; Kraus, Zachary; Dement-Brown, Jessica; Alabi, Oyeleye; Starost, Kyle; Tolnay, Mate.
Afiliação
  • Agarwal S; Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
  • Kraus Z; Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
  • Dement-Brown J; Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
  • Alabi O; Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
  • Starost K; Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
  • Tolnay M; Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA. Electronic address: mate.tolnay@fda.hhs.gov.
Cell Rep ; 30(5): 1292-1299.e3, 2020 02 04.
Article em En | MEDLINE | ID: mdl-32023449
ABSTRACT
Human Fc receptor-like 3 (FCRL3) is an orphan receptor expressed by lymphocytes, including regulatory T cells. FCRL3 is implicated in several autoimmune diseases; however, its function on regulatory T cells is unknown. We discovered that FCRL3 stimulation of regulatory T cells inhibited their suppressive function. Moreover, FCRL3 stimulation induced IL-17, IL-26, and IFNγ production and promoted expression of the Th17-defining transcription factor RORγt without affecting FOXP3 expression. We suggest that FCRL3 engagement mediates a transition of regulatory T cells to a pro-inflammatory Th17-like phenotype. In addition, we identified secretory IgA as a specific FCRL3 ligand. Secretory IgA could serve as an environmental cue for mucosal breaches and locally drive regulatory T cell plasticity to help control infection. Our findings define a mechanism that explains the recognized association of FCRL3 with autoimmune diseases. Targeting FCRL3 to modulate regulatory T cell activity could be exploited to treat both malignancies and autoimmune diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina A Secretora / Receptores Imunológicos / Linfócitos T Reguladores Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina A Secretora / Receptores Imunológicos / Linfócitos T Reguladores Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos